Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
A bufadienolide-enriched fraction of Bryophyllum pinnatum effectively inhibits myometrium contractility in vitro
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4500785
Author(s) Santos, Stefanie; Haslinger, Christian; Klaic, Kristian; Faleschini, Maria Teresa; Mennet, Mónica; Potterat, Olivier; von Mandach, Ursula; Hamburger, Matthias; Simoes-Wüst, Ana Paula
Author(s) at UniBasel Hamburger, Matthias
Faleschini, Maria Teresa
Potterat, Olivier
Year 2019
Title A bufadienolide-enriched fraction of Bryophyllum pinnatum effectively inhibits myometrium contractility in vitro
Journal Planta Medica
Volume 85
Number 05
Pages / Article-Number 385-393
Abstract Bryophyllum pinnatum has been used since the 1970s to prevent premature labour, first in anthroposophic hospitals and, more recently, also in the main Swiss perinatal centres. However, it is not known which compounds in B. pinnatum leaves contribute to the tocolytic effect. Here we studied the effects of a flavonoid-enriched fraction, the corresponding flavonoid aglycon mixture, a bufadienolide-enriched fraction, and B. pinnatum leaf press juice on human myometrial contractility in vitro. The strength (area under the curve and amplitude) and frequency of contractions were recorded using strips of human myometrium mounted in an organ bath system. Cell viability assays were performed with the human myometrium hTERT-C3 and PHM1 – 41 cell lines. Repeated addition of the flavonoid-enriched fraction, flavonoid aglycon mixture, bufadienolide-enriched fraction, or B. pinnatum leaf press juice led to a progressive decrease of contraction strength, without jeopardising the vitality of myometrium strips. The bufadienolide-enriched fraction was the most active, since 1 µg/mL of the bufadienolide-enriched fraction lowered the area under the curve to 40.1 ± 11.8% of the initial value, whereas 150 µg/mL of the flavonoid-enriched fraction, 6.2 µg/mL of the flavonoid aglycon mixture, and 10 µg/mL of the B. pinnatum leaf press juice were required to achieve comparable inhibition. A progressive increase of contraction frequency was observed, except in the case of the flavonoid aglycon mixture, which did not affect frequency. None of the test substances decreased myometrial cell viability, even at concentrations of 500 µg/mL of the flavonoid-enriched fraction, 40 µg/mL of the flavonoid aglycon mixture, 3.8 µg/mL of the bufadienolide-enriched fraction, and 75 µg/mL of the B. pinnatum leaf press juice, i.e., higher than those used in the myometrium experiments. Given the concentrations of flavonoids in the flavonoid-enriched fraction and B. pinnatum leaf press juice, and of bufadienolides in the bufadienolide-enriched fraction and B. pinnatum leaf press juice, it appears that bufadienolides may be mainly responsible for the relaxant effect.
Publisher Georg Thieme
ISSN/ISBN 1612-1791 ; 2199-157X
edoc-URL https://edoc.unibas.ch/70143/
Full Text on edoc No
Digital Object Identifier DOI 10.1055/a-0810-7704
 
   

MCSS v5.8 PRO. 0.321 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
29/03/2024